Press Releases
Press Releases
| Date | Press Releases | Topic |
|---|---|---|
| Oct 5, 2006 |
"The Pew Charitable Trusts extends our warmest congratulations to Craig C. Mello, Ph.D., on his achievement in winning the Nobel Prize in Medicine. Dr. Mello was selected in 1995 as a Pew Scholar in the Biomedical Sciences, receiving support over four years for his research on RNA interference - an investigation that ultimately led to his award-winning discovery..." |
Biomedical Research |
| Sep 27, 2006 |
Lax Oversight of Genetic Tests Better oversight of genetic testing laboratories by the Centers for Medicare and Medicaid Services (CMS) is “critical to ensuring the quality of genetic testing in the United States,” and failure to provide it “poses a risk to the public’s health,” according to a Petition for Rulemaking submitted today to CMS Administrator Mark McClellan by the Genetics and Public Policy Center, Public Citizen, and Genetic Alliance. |
|
| Aug 8, 2006 |
Improvement Needed in Genetic Testing Oversight In recent months many health-related organizations have joined in calling on the Centers for Medicare and Medicaid Services (CMS) to end years of delay in assuring the safety and accuracy of genetic testing. In separate letters to CMS Administrator Mark McClellan, members of Genetic Alliance and a coalition of women’s health groups urged the agency to issue a proposed rule to create a genetic testing specialty under the Clinical Laboratory Improvement Amendments (CLIA) of 1988. |
|
| Aug 4, 2006 |
New Bill Could Jumpstart The Setting of Sound Genetic Public Policy Sen. Barack Obama (D-IL) introduced legislation to improve development and appropriate use of genetic tests in the United States, the Genetics and Public Policy Center has learned. "The Obama bill accelerates advances in the beneficial applications of genetic technologies to human health, while ensuring appropriate safeguards for the quality of genetic testing," says Center Director Kathy Hudson. |
|
| Jul 27, 2006 |
Oversight Gaps for Genetic Testing Pose Risks to Public Health At the invitation of the Senate Special Committee on Aging, Genetics and Public Policy Center Director Kathy Hudson testified on Thursday, July 27 as part of the hearing "At Home DNA Tests: Marketing Scam or Medical Breakthrough?" Hudson made the case that poor oversight of genetic testing has led to a situation in which "there is no way for a consumer to distinguish between the dubious and the decent" genetic tests and the laboratories that perform them. |
|
| Jun 20, 2006 |
Seven Latin American Scientists Awarded Opportunity to Pursue Cutting-Edge Biomedical Research Seven highly talented early-career Latin American scientists were named today as 2006 Pew Latin American Fellows in the Biomedical Sciences by The Pew Charitable Trusts and the University of California at San Francisco (UCSF). |
Biomedical Research |
| Jun 20, 2006 |
Fifteen of the nation’s most promising early- to mid-career biomedical researchers were named today as 2006 Pew Scholars in the Biomedical Sciences by The Pew Charitable Trusts and the University of California at San Francisco (UCSF). |
Biomedical Research |
| Dec 16, 2005 |
In light of a decision expected soon by the World Trade Organization (WTO) on the U.S. challenge to the European Union (EU) policy on genetically modified (GM) foods, the Pew Initiative on Food and Biotechnology has updated its brief on the trade dispute between the U.S. and the EU over agricultural biotechnology. |
Food Safety |
| Dec 12, 2005 |
The Pew Charitable Trusts Supports U.S. Pandemic Planning Project In response to the threat that avian flu could transition into a human pandemic, The Pew Charitable Trusts announced today a $1.5 million investment to ensure that key decision makers at the federal, state and local levels are responsibly developing and executing plans to protect Americans from this or other widespread public health threats. |
|
| Dec 6, 2005 |
In March and May 2005, the Pew Initiative on Food and Biotechnology hosted workshops to explore issues related to the regulation and commercialization of the products of animal biotechnology. Participants included animal biotechnology researchers from academia and industry; other representatives from the biotechnology, food, and agriculture industries; consumer, environmental, and animal welfare advocates; ethicists; and federal agency officials. |
Food Safety |
